Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2023-09-12 00:00:00 ET · period of report 2023-09-11 · accession 0001437749-23-025634 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-12 | 2023-09-11 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $0.5287 | +9,000 | 121.5K | +8% | +$4,758 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-11 | P | A | 4,000 | $0.53 | 125,500 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |
| 2 | Common | Common Stock | 2023-09-11 | P | A | 1,200 | $0.52 | 117,700 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |
| 3 | Common | Common Stock | 2023-09-11 | P | A | 3,800 | $0.53 | 121,500 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |